Bicara Therapeutics Exec Cohlhepp Ryan Buys Shares in Quiet Confidence Boost for Investor Sentiment
Ryan’s March 3 insider buy of Bicara shares—just above market price—signals steady confidence in the company’s pipeline and could hint at future upside, but volatility may rise amid upcoming milestones.
4 minutes to read